Oisín Biotechnologies
Oisin Biotechnologies is a preclinical biotechnology company that focuses on developing drugs against ageing
Oisin Biotechnologies is a platform drug development company focused on creating drugs to combat a variety of age related diseases.
Our proprietary technology gives persistently senescent cells a helping hand to “do the right thing." By providing an exogenous apoptotic gene, which is only transiently expressed in cells that already have the p16 gene active, we can precisely induce the senescent cell to commit suicide. Oisín has shown as much as an 80% reduction in senescent cells in cell culture and significant reductions of senescent cell burden in naturally aged mice.
Visit website: https://www.oisinbio.com
Details last updated 31-May-2020
Oisín Biotechnologies News
Oisín Biotechnologies' gene therapy may be available in the next 5 years
Longevity Technology - 22-Jan-2021
Results in mice suggest that it can increase median lifespan in humans by 15 years
Read more...Oisín made it to top 10 breakthrough technologies of 2020
Business Wire - 26-Feb-2020
Will begin clinical trials after completing pre-clinical studies
Read more...